In vitro permeation studies of triamcinolone acetonide mouthwashes

International Journal of Pharmaceutics

Volumn 220, Issue 1-2, 2001, Pages 111-117

  Ungphaiboon, Suwipa ^a   Maitani, Yoshie ^b  

^a PRINCE OF SONGKLA UNIVERSITY   (Thailand)

^b HOSHI UNIVERSITY   (Japan)

Author keywords

Mouthwash; Oral lichen planus; Permeation; Triamcinolone acetonide

Indexed keywords

ALCOHOL; CARBOMER; CARBOMER 934; ORABASE; SOLVENT; TRIAMCINOLONE ACETONIDE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; AQUEOUS SOLUTION; ARTICLE; CHEEK MUCOSA; CHEEK POUCH; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG FORMULATION; DRUG PENETRATION; DRUG TRANSPORT; HAMSTER; MALE; MOUTHWASH; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CARBOXYMETHYLCELLULOSE; CHEEK; CHEMISTRY, PHARMACEUTICAL; CRICETINAE; DRUG CARRIERS; MEMBRANES, ARTIFICIAL; MOUTH MUCOSA; MOUTHWASHES; SOLVENTS; TRIAMCINOLONE ACETONIDE;

EID: 0035806328     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(01)00665-2     Document Type: Article

References (22)

1. 14C-triamcinolone acetonide. J. Pharm. Sci. 65:1976;429-430.
2. Chidambaram N., Srivatsava A.K. Buccal drug delivery systems. Drug Dev. Ind. Pharm. 21:1995;1009-1036.
3. Chow D.S-L., Kaka L., Wang T.I. Concentration dependent enhancement of 1-dodecylazacycloheptan-2-one on the percutaneous penetration kinetics of triamcinolone acetonide. J. Pharm. Sci. 73:1984;1794-1799.
4. Coutel-Egros A., Maitani Y., Veillard M., Machida Y., Nagai T. Combined effects of pH, cosolvent and penetration enhancers on the in vitro buccal absorption of propranolol through excised hamster cheek pouch. Int. J. Pharm. 84:1992;117-128.
5. Eisen D. The therapy of oral lichen planus. Crit. Rev. Oral Biol. Med. 4:1993;141-158.
6. Harris D., Robinson J.R. Drug delivery via the mucous membranes of the oral cavity. J. Pharm. Sci. 81:1992;1-10.
7. Kadir R., Barry B.W. Bisabolol, a possible safe penetration enhancer for dermal and transdermal therapeutics. Int. J. Pharm. 70:1991;87-94.
8. Kamath K.R., Park K. Mucoadhesive preparations. Swarbrick J., Boylan J.C. Encyclopedia of Pharmaceutical Technology. 10:1990;133-163 Marcel Dekker, New York.
9. Marek C.L. Issues and opportunities: compounding for dentistry. Int. J. Pharm. Compound. 3:1999;4-7.
10. Nagai T. Adhesive topical drug delivery system. J. Control. Rel. 2:1985;121-134.
11. Pader M. Oral rinses. Cosm. Toil. 109:1994;59-68.
12. Rathbone M.J., Hadgraft J. Absorption of drugs from the human oral cavity. Int. J. Pharm. 74:1991;9-24.
13. Raynolds E.F. Martindale, The Extra Pharmacopoeia. 28th Ed. 1993;739 The Pharmaceutical Press, London.
14. Sasaki H., Kojima M., Mori Y., Nakamura J., Shibasaki J. Enhancing effect of pyrrolidone derivatives on transdermal penetration of 5-fluorouracil, triamcinolone acetonide, indometacin and flurbiprofen. J. Pharm. Sci. 80:1991;533-538.
15. Shojaei A.H. Buccal mucosa as a route for systemic drug delivery: a review. J. Pharm. Pharmaceut. Sci. 1:1998;15-30.
16. Squier C.A., Wertz P.W. Structure and function of oral mucosa. Rathbone M.J. Oral mucosal drug delivery. 1996;14-15 Marcel Dekker, New York.
17. Stalker D.J., Pollock S.R. Bioavailability of flurbiprofen following buccal administration. Pharm. Res. 8:1991;605-607.
18. Surber C., Wilhem K., Hori M., Maibach H.I., Guy R.H. Optimization of topical therapy: Partition of drugs into stratum corneum. Pharm. Res. 7:1990;1320-1324.
19. Sveinsson S.J., Holbrook W.P. Oral mucosal adhesive ointment containing liposomal corticisteroid. Int. J. Pharm. 95:1993;105-109.
20. Sveinsson S.J., Mezei M. In vitro oral mucosal absorption of liposomal triamcinolone acetonide. Pharm. Res. 9:1992;1359-1361.
21. Vincent S.D. Diagnosing and managing oral lichen planus. JADA. 12:1991;93-96.
22. ® in humans in vivo. Int. J. Pharm. 66:1990;53-62.